Paul Scott on Muck Rack

Paul Scott

Rochester
As seen in: Daily Mail, The Conversation, Outside Magazine, rsc.org, Pioneer Press, Runner's World, Journal of Intellectual Property Law & Practice, The Lancet, The News & Observer, The Advocate (Baton Rouge, LA) and
Author, Malcharist. Journalism, criticism, humor, essays, etc. Currently on hiatus.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Safety and immunogenicity of a next-generation live-attenuated yellow fever vaccine produced in a Vero cell line in the USA: a phase 1 randomised, observer-blind, active-controlled, dose-ranging clinical trial

|
By Kayvon Modjarrad, Paul Scott, Melanie McCauley
| The Lancet
Background Recent outbreaks between 2015–17 and production delays have led to a yellow fever vaccine shortage. Therefore, there is an urgent need for new yellow fever vaccines with improved production scalability. A next-generation live-attenuated yellow fever vaccine candidate (vYF), produced in a Vero cell line has shown similar immunogenicity to licensed yellow fever vaccines in preclinical studies.
Open in Who Shared Issue with article?

SARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial

|
By Paul Scott, Jack N. Hutter, Christine Lee
| The Lancet
Summary A self-assembling SARS-CoV-2 WA-1 recombinant spike ferritin nanoparticle (SpFN) vaccine co-formulated with Army Liposomal Formulation (ALFQ) adjuvant containing monophosphoryl lipid A and QS-21 (SpFN/ALFQ) has shown protective efficacy in animal challenge models. This trial aims to assess the safety and immunogenicity of SpFN/ALFQ in a first-in-human clinical trial.
Open in Who Shared Issue with article?

Learn What Theories Explain in a Psychology Assignment?

|
By Paul Scott, Paul Scott
| PaidForArticles
The psychology assignment includes various theories and descriptions of human behaviour. However, the area of living being’s activities does not adjust in some perceptions. It is a considerable collection of data studied by the researchers and is based on reasons. The article describes some crucial theories on the subject. If you are confused about it or seeking psychology assignment help, you must go through it once. It will surely clear some of your doubts about psychology and the reason behind it.
Open in Who Shared Issue with article?
See all 5,258 licensed articles (5,275 Total)

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Paul

Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified